Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 1/20 | 0.58 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.55 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.55 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.55 |
| ▸ | EPHA2 | P29317 | 2/20 | 0.54 |
| ▸ | BDKRB2 | P30411 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30974592 | 0.94 | F2 (0.58) | F2OPRM1OPRD1OPRK1EPHA2 | |
| SCHEMBL30782709 | 0.93 | OPRM1 (0.62) | F2OPRM1OPRD1OPRK1EPHA2 | |
| SCHEMBL6497247 | 0.91 | F2 (0.57) | F2OPRM1OPRD1OPRK1 | |
| SCHEMBL2778544 | 0.91 | F2 (0.57) | F2OPRM1OPRD1OPRK1 | |
| SCHEMBL2778546 | 0.91 | F2 (0.57) | F2OPRM1OPRD1OPRK1 | |
| SCHEMBL2119635 | 0.91 | F2 (0.57) | F2OPRM1OPRD1OPRK1 | |
| SCHEMBL6850160 | 0.91 | F2 (0.57) | F2OPRM1OPRD1OPRK1 | |
| SCHEMBL30773462 | 0.91 | F2 (0.55) | F2OPRM1OPRD1OPRK1EPHA2 | |
| SCHEMBL30940242 | 0.91 | NMUR2 (0.55) | F2OPRM1OPRD1EPHA2 | |
| SCHEMBL29934589 | 0.91 | OPRM1 (0.58) | F2OPRM1OPRD1OPRK1EPHA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240069013-A1 | GLOBAL PROTEOMIC SCREENING OF RANDOM BEAD ARRAYS USING MASS SPECTROMETRY IMAGING | AMBERGEN, INC. | 2024-02-29 | — | — | US | disclosed |
| US-11782056-B2 | Global proteomic screening of random bead arrays using mass spectrometry imaging | AMBERGEN, INC. (US) | 2023-10-10 | — | — | US | disclosed |